Unmasking the janus faces of autophagy in obesity-associated insulin resistance and cardiac dysfunction

被引：36

作者：

Xu, Xihui ^{[1
]}

Ren, Jun ^{[1
]}

机构：

[1] Univ Wyoming, Sch Pharm, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA

来源：

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2012年 / 39卷 / 02期

关键词：

autophagy; cardiovascular disease; heart; insulin resistance; obesity; HIGH-FAT-DIET; ACTIVATED PROTEIN-KINASE; BETA-CELL; CARDIOVASCULAR-DISEASE; HEMODYNAMIC STRESS; GLUCOSE-METABOLISM; LIPID-METABOLISM; SELF-DIGESTION; RISK-FACTOR; RAT-LIVER;

D O I：

10.1111/j.1440-1681.2011.05638.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

1. Autophagy is an intracellular, lysosomal-dependent process involved in the turnover of long-lived proteins, damaged organelles and other subcellular structures. The autophagic process is known to play an essential role in the maintenance of cellular homeostasis. Results from recent studies also indicate an important role for the autophagic process in the pathogenesis of human diseases, including cancer, cardiovascular diseases, obesity, diabetes mellitus and ageing.

引用

页码：200 / 208

页数：9

共 50 条

[31] Role of Adipose Tissue in Obesity-Associated Insulin Resistance and Diabetes Mellitus
Fasshauer, M.
DIABETOLOGIE UND STOFFWECHSEL, 2012, 7 (04) : 287 - 289
[32] Osteopontin deficiency prevents obesity-associated hepatic steatosis and insulin resistance
Kiefer, F. W.
Zeyda, M.
Neschen, S.
Gollinger, K.
Pfau, B.
Neuhofer, A.
Weichhart, T.
Kenner, L.
Stulnig, T. M.
DIABETOLOGIA, 2009, 52 : S33 - S33
[33] Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery
Jaakko Mäkinen
Jarna C. Hannukainen
Anna Karmi
Heidi M. Immonen
Minna Soinio
Lassi Nelimarkka
Nina Savisto
Mika Helmiö
Jari Ovaska
Paulina Salminen
Patricia Iozzo
Pirjo Nuutila
Diabetologia, 2015, 58 : 1055 - 1062
[34] Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery
Makinen, Jaakko
Hannukainen, Jarna C.
Karmi, Anna
Immonen, Heidi M.
Soinio, Minna
Nelimarkka, Lassi
Savisto, Nina
Helmio, Mika
Ovaska, Jari
Salminen, Paulina
Iozzo, Patricia
Nuutila, Pirjo
DIABETOLOGIA, 2015, 58 (05) : 1055 - 1062
[35] Targeting Autophagy in Obesity-Associated Heart Disease
Castaneda, Diana
Gabani, Mohanad
Choi, Soo-Kyoung
Quynh My Nguyen
Chen, Cheng
Mapara, Ayesha
Kassan, Adam
Gonzalez, Alexis A.
Ait-Aissa, Karima
Kassan, Modar
OBESITY, 2019, 27 (07) : 1050 - 1058
[36] Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
Al-Sulaiti, Haya
Diboun, Ilhame
Agha, Maha V.
Mohamed, Fatima F. S.
Atkin, Stephen
Domling, Alex S.
Elrayess, Mohamed A.
Mazloum, Nayef A.
JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
[37] T-bet has a role in obesity-associated insulin resistance
Nature Reviews Endocrinology, 2013, 9 (7) : 380 - 380
[38] Osteopontin: A mediator of Obesity-associated hepatic Steatosis and Insulin resistance.
Kiefer, Florian
Zeyda, Maximilian
Neschen, Susanne
Gollinger, Karina
Pfau, Birgit
Neuhofer, Angelika
Weichhart, Thomas
Kenner, Lukas
Stulnig, Thomas
WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S17 - S17
[39] Gut Bacteria as Key Players in Obesity-Associated Inflammation and Insulin Resistance
Lang, Les
GASTROENTEROLOGY, 2010, 139 (05) : 1435 - 1435
[40] Cystatin C alleviates obesity-associated tissue inflammation and insulin resistance
Dedual, M. A.
Wueest, S.
Aeppli, T. R. J.
Challa, T. D.
Konrad, D.
DIABETOLOGIA, 2018, 61 : S267 - S267

← 1 2 3 4 5 →